Success Metrics

Clinical Success Rate
84.0%

Based on 68 completed trials

Completion Rate
84%(68/81)
Active Trials
11(8%)
Results Posted
29%(20 trials)
Terminated
13(9%)

Phase Distribution

Ph phase_2
21
15%
Ph phase_4
33
24%
Ph phase_3
30
21%
Ph not_applicable
28
20%
Ph phase_1
15
11%
Ph early_phase_1
2
1%

Phase Distribution

17

Early Stage

21

Mid Stage

63

Late Stage

Phase Distribution129 total trials
Early Phase 1First-in-human
2(1.6%)
Phase 1Safety & dosage
15(11.6%)
Phase 2Efficacy & side effects
21(16.3%)
Phase 3Large-scale testing
30(23.3%)
Phase 4Post-market surveillance
33(25.6%)
N/ANon-phased studies
28(21.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.3%

68 of 94 finished

Non-Completion Rate

27.7%

26 ended early

Currently Active

11

trials recruiting

Total Trials

140

all time

Status Distribution
Active(14)
Completed(68)
Terminated(26)
Other(32)

Detailed Status

Completed68
unknown32
Withdrawn13
Terminated13
Recruiting9
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
140
Active
11
Success Rate
84.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.6%)
Phase 115 (11.6%)
Phase 221 (16.3%)
Phase 330 (23.3%)
Phase 433 (25.6%)
N/A28 (21.7%)

Trials by Status

withdrawn139%
completed6849%
recruiting96%
not_yet_recruiting32%
active_not_recruiting21%
terminated139%
unknown3223%

Recent Activity

Clinical Trials (140)

Showing 20 of 140 trialsScroll for more
NCT06453876Phase 3

Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)

Not Yet Recruiting
NCT05848713Phase 3

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Recruiting
NCT06549842Not Applicable

Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial

Completed
NCT02653092Not Applicable

Reprometabolic Syndrome Mediates Subfertility in Obesity

Active Not Recruiting
NCT04374799Phase 3

Heparin vs Placebo for Cardiac Catheterization

Recruiting
NCT04227678Not Applicable

Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

Recruiting
NCT02591199Phase 2

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Terminated
NCT06080074Phase 2

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Recruiting
NCT06381661Phase 2

Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial

Not Yet Recruiting
NCT05737121Phase 2

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

Recruiting
NCT00508924Phase 2

Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)

Completed
NCT06822426Phase 3

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Recruiting
NCT03537586Not Applicable

A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

Active Not Recruiting
NCT04536272Phase 3

Reduced Anticoagulation Targets in ECLS (RATE)

Completed
NCT00277394Phase 4

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Completed
NCT02651428Phase 3

Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection

Completed
NCT05886998Phase 3

Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury

Completed
NCT06676085Not Applicable

A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

Recruiting
NCT06583889Not Applicable

Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)

Recruiting
NCT03867851Phase 2

Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
140